Görünmez Engellilik ve Değerlendirme Prensipleri

Yazarlar

Seher Nasırcılar Ülker
https://orcid.org/0000-0002-7041-2209

Özet

Görünmez engeller, bireylerin yaşam kalitesini fiziksel, psikolojik ve sosyal düzeylerde önemli ölçüde etkileyebilen, dışarıdan fark edilmeyen sağlık sorunlarıdır. Bu bölümde fibromiyalji, migren, ruhsal bozukluklar, nörogelişimsel ve otoimmün hastalıklar gibi çeşitli durumlar ele alınmakta ve ilgili değerlendirme araçları ile ilkeler özetlenmektedir. Hasta odaklı, empatik ve multidisipliner yaklaşımların önemi vurgulanmakta; öznel semptomların geçerliliğinin tanınması, işlevsel sınırlılıkların ve damgalanmanın anlaşılması gerekliliği ifade edilmektedir. Hasta anlatımları, klinik değerlendirmenin kritik bir parçası olarak kabul edilmektedir. Görünmez engelliliklerin tanı ve yönetiminde sağlık profesyonellerinin farkındalık düzeyinin artırılması, daha adil ve kapsayıcı sağlık hizmetleri sunulmasına katkı sağlayacaktır.

Referanslar

Shakespeare T. Disability rights and wrongs revisited . 2nd ed. Routledge; 2017.

Doğanavşargil Baysal GÖ. Damgalanma ve Ruh Sağlığı. Arşiv Kaynak Tarama Dergisi. 2013;22(2):239–51.

Perrot S. Fibromyalgia: A misconnection in a multiconnected world? European Journal of Pain. 2019 May 11;23(5):866–73.

Ballantyne JC, Sullivan MD. Intensity of Chronic Pain — The Wrong Metric? New England Journal of Medicine. 2015 Nov 26;373(22):2098–9.

Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991 May;18(5):728–33.

Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009 Aug 10;11(4):R120.

Salaffi F, Franchignoni F, Giordano A, Ciapetti A, Sarzi-Puttini P, Ottonello M. Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis. Clin Exp Rheumatol. 2013;31(6 Suppl 79):S41-9.

Iannuccelli C, Sarzi-Puttini P, Atzeni F, Cazzola M, di Franco M, Guzzo MP, et al. Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia. Clin Exp Rheumatol. 2011;29(6 Suppl 69):S49-54.

Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, et al. Validation of the Fibromyalgia Survey Questionnaire within a Cross-Sectional Survey. PLoS One. 2012 May 25;7(5):e37504.

Häuser W, Brähler E, Wolfe F, Henningsen P. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: Surveys with patients of three different settings. J Psychosom Res. 2014 Apr;76(4):307–11.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan 25;38(1):1–211.

Seddik AH, Branner JC, Ostwald DA, Schramm SH, Bierbaum M, Katsarava Z. The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany. Cephalalgia. 2020 Dec 6;40(14):1551–60.

Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001 Mar;56(suppl_1).

Kosinski M, Bayliss MS, Bjorner JB, Ware Jr. JE, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Quality of Life Research. 2003;12(8):963–74.

Freyd M. The Graphic Rating Scale. J Educ Psychol. 1923 Feb;14(2):83–102.

Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 Jun;26(6):742–6.

Martel JW, Potter SB. Evaluation and Management of Neck and Back Pain. Semin Neurol. 2019 Feb;39(1):41–52.

Caridi JM, Pumberger M, Hughes AP. Cervical Radiculopathy: A Review. HSS J. 2011 Oct 1;7(3):265–72.

Thomas DB, Oenning NSX, Goulart BNGD. Essential aspects in the design of data collection instruments in primary health research. Revista Cefac. 2018;20(5):657–64.

Chiarotto A, Maxwell LJ, Ostelo RW, Boers M, Tugwell P, Terwee CB. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review. J Pain. 2019 Mar;20(3):245–63.

Azevedo VD, Ferreira Silva RM, de Carvalho Borges SC, Fernades M da SV, Miñana-Signes V, Monfort-Pañego M, et al. Instruments for assessing back pain in athletes: A systematic review. PLoS One. 2023 Nov 3;18(11):e0293333.

Misailidou V, Malliou P, Beneka A, Karagiannidis A, Godolias G. Assessment of patients with neck pain: a review of definitions, selection criteria, and measurement tools. J Chiropr Med. 2010 Jun;9(2):49–59.

Karamustafalıoğlu O, Yumrukçal H. Depresyon ve anksiyete bozuklukları. Sisli Etfal Hastan Tıp Bul. 2011;45(2).

BECK AT. An Inventory for Measuring Depression. Arch Gen Psychiatry. 1961 Jun 1;4(6):561.

Reich H, Rief W, Brähler E, Mewes R. Cross-cultural validation of the German and Turkish versions of the PHQ-9: an IRT approach. BMC Psychol. 2018 Dec 5;6(1):26.

Mantar A. Anksiyete Duyarlılığı İndeksi-3’ün Türkçe formunun geçerlik ve güvenilirlik çalışması . 2008;

Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988 Jan;14(1):61–8.

KONKAN R, ŞENORMANCI Ö, GÜÇLÜ O, AYDIN E, SUNGUR MZ. Validity and reliability study for the Turkish adaptation of the generalized anxiety disorder-7 (GAD-7) scale. Arch Neuropsychiat. 2013;50:53–8.

Neurological, Psychiatric, and Developmental Disorders. Washington, D.C.: National Academies Press; 2001.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013.

Nikolitch K, Saraf G, Solmi M, Kroenke K, Fiedorowicz JG. Fire and Darkness: On the Assessment and Management of Bipolar Disorder. Medical Clinics of North America. 2023 Jan;107(1):31–60.

Faraone S V., Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1(1):15020.

Ellerbeck K, Smith C, Courtemanche A. Care of Children with Autism Spectrum Disorder. Primary Care: Clinics in Office Practice. 2015 Mar;42(1):85–98.

Constantino JN. Social Responsiveness Scale. In: Encyclopedia of Autism Spectrum Disorders. Cham: Springer International Publishing; 2021. p. 4457–67.

Bajre P, Khan A. Developmental dyslexia in Hindi readers: Is consistent sound‐symbol mapping an asset in reading? Evidence from phonological and visuospatial working memory. Dyslexia. 2019 Nov 20;25(4):390–410.

Fletcher JM, Miciak J. Comprehensive Cognitive Assessments are not Necessary for the Identification and Treatment of Learning Disabilities. Archives of Clinical Neuropsychology. 2017 Feb 1;32(1):2–7.

Burns MK, Petersen-Brown S, Haegele K, Rodriguez M, Schmitt B, Cooper M, et al. Meta-analysis of academic interventions derived from neuropsychological data. School Psychology Quarterly. 2016 Mar;31(1):28–42.

Hu Y, Nie H, Yu HH, Qin C, Wu LJ, Tang ZP, et al. Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Autoimmun Rev. 2019 May;18(5):542–8.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis. Neurology. 1983 Nov;33(11):1444–1444.

Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Multiple Sclerosis Journal. 1999 Aug 1;5(4):244–50.

Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, et al. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology. 1996 Jul;47(1):129–39.

Lee KC, Carson L, Kinnin E, Patterson V. The Ashworth Scale: A Reliable and Reproducible Method of Measuring Spasticity. Neurorehabil Neural Repair. 1989 Jan 1;3(4):205–9.

Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain. 2006 Jan 1;129(1):224–34.

Berg K. Measuring balance in the elderly: preliminary development of an instrument. Physiotherapy Canada. 1989 Nov;41(6):304–11.

Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, et al. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci. 2006 Jan;240(1–2):77–80.

Hobart J. The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure. Brain. 2001 May 1;124(5):962–73.

Verheyden G, Nuyens G, Nieuwboer A, Van Asch P, Ketelaer P, De Weerdt W. Reliability and Validity of Trunk Assessment for People With Multiple Sclerosis. Phys Ther. 2006 Jan 1;86(1):66–76.

Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: A critical review. J Autoimmun. 2014 Feb;48–49:10–3.

Chauhan K, Jandu JS, Brent LH, Al-Dhahir MA. Rheumatoid Arthritis. 2025.

Justiz Vaillant AA, Goyal A, Varacallo MA. Systemic Lupus Erythematosus. 2025.

Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J Autoimmun. 2021 May;119:102615.

Colombel JF, Shin A, Gibson PR. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clinical Gastroenterology and Hepatology. 2019 Feb;17(3):380-390.e1.

Lee JS, Kim ES, Moon W. Chronological Review of Endoscopic Indices in Inflammatory Bowel Disease. Clin Endosc. 2019 Mar 31;52(2):129–36.

McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. 2025.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S62-9.

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Summary of Revisions: Standards of Care in Diabetes—2023. Diabetes Care. 2023 Jan 1;46(Supplement_1):S5–9.

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. 2009 Jul 1;32(7):1327–34.

KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;3(1):1–150.

Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013;11(1):138.

Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul 1;23(7):943–50.

Epstein RM, Street RL. The Values and Value of Patient-Centered Care. The Annals of Family Medicine. 2011 Mar 1;9(2):100–3.

Tabak RS. Sağlık İletişimi. Ankara; 2013.

Evidence-Based History-Taking Approach. In: Evidence-Based Physical Examination Handbook. New York, NY: Springer Publishing Company; 2020.

Stuart GW. Principles and Practice of Psychiatric Nursing. 10th ed. Elsevier Health Sciences; 2013.

Ankaralı H, Ataoğlu S, Ankaralı S. Fibromiyalji Hastalarının Yaşam Kalitesini Değerlendirmede Kullanılan Ölçeklerin Karşılaştırılması. Anadolu Kliniği Tıp Bilimleri Dergisi. 2017 Mar 24;22(2).

International Classification of Functioning, Disability and Health (ICF). World Health Organization; 2001.

Law M, Baum CM, Dunn W. Measuring occupational performance: Supporting best practice

Yayınlanan

19 Ocak 2026

Lisans

Lisans